We have engineered a genomic HDV ribozyme to construct several trans-acting ribozymes for use in trans to cleave target RNAs. Among the 10 different combinations attempted, only HDV88-Trans had cleavage activity on the 13-nucleotide substrate, R13, in vitro. To improve the cleavage efficiency, at least in vitro, of the HDV88-Trans ribozyme (kclv=0.022 min-l), we have constructed several variants that differ in forming stem II (length) in the pseudoknot secondary structure model. When cleavage rate constants were analyzed and compared among variants of HDV88-Trans, HDV88-Trans~4 yielded kdv = 1.7 min 1. HDV88-Trans-4 thus represents the highest active genomic HDV ribozyme that functions in trans thus far constructed, and has activity under physiological conditions (pH 7.1 at 37°C with 1 mM of MgCl2).Key words. HDV ribozyme; Pseudoknot structure; Ribozyme, trans-acting to cleave target RNAs, cis-acting (intramolecular) ribozymes were dissected into substrates and enzymes. Earlier, efficient trans-acting hammerhead and hairpin ribozymes were constructed and showed that they function very efficiently both in vitro and in vivo [7]. Similarly, both genomic and antigenomic HDV ribozymes have been dissected into substrates and enzymes, but not yet analyzed as extensively as hammerhead and hairpin ribozymes. To increase their activity, nonphysiological conditions, such as high temperature and denaturants, have been used in reaction conditions.In the present study, we engineered the genomic HDV ribozyme to construct several trans-acting ribozymes to use in trans to cleave target RNAs. We succeeded in increasing their activity under physiological reaction conditions.
Materials and methods